Hypoglycemic mechanism of a novel proteoglycan, extracted from Ganoderma lucidum, in hepatocytes
- PMID: 29233661
- DOI: 10.1016/j.ejphar.2017.12.020
Hypoglycemic mechanism of a novel proteoglycan, extracted from Ganoderma lucidum, in hepatocytes
Abstract
Protein tyrosine phosphatase 1 B (PTP1B) is one of main causes involved in type 2 diabetes, it dephosphorylates insulin receptor substrate (IRS) and dysregulates insulin signaling pathway, thus inducing insulin resistance. Our previous work first reported that FYGL, a neutral hyperbranched proteoglycan ingredient extracted from Ganoderma lucidum, has hypoglycemic activity in vivo and inhibitory potency on PTP1B in vitro, but the underlying mechanism was still unclear. In this study, we sought to investigate effects of FYGL on insulin signaling pathway involved with PTP1B as the targeting point in hepatocytes. We found that FYGL inhibited overexpression of PTP1B in liver tissues of ob/ob mice and HepG2 cells, significantly improved the phosphorylation of IRS1 on tyrosine residues, activated phosphatidylinositol-3 kinase (PI3K)/protein kinase B (Akt) cascades and increased phosphorylation of glycogen synthesis kinase-3β (GSK3β), finally enhanced insulin-stimulated glycogen synthesis in HepG2 cells and decreased blood glucose in insulin resistance model mice. Our study clearly illustrated the hypoglycemic mechanism of a novel proteoglycan possibly used in type 2 diabetes management in vivo.
Keywords: GSK3β; Ganoderma lucidum; Hepatocytes; PTP1B inhibitor; Proteoglycan.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway.Food Funct. 2018 Jan 24;9(1):397-406. doi: 10.1039/c7fo01489a. Food Funct. 2018. PMID: 29215104
-
Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.Br J Nutr. 2012 Dec 14;108(11):2014-25. doi: 10.1017/S0007114512000153. Epub 2012 Mar 27. Br J Nutr. 2012. PMID: 22453054
-
Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats.Eur Rev Med Pharmacol Sci. 2012 Feb;16(2):166-75. Eur Rev Med Pharmacol Sci. 2012. PMID: 22428467
-
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.Dan Med J. 2014 Jul;61(7):B4890. Dan Med J. 2014. PMID: 25123125 Review.
-
Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Diabetes.Adv Exp Med Biol. 2019;1182:201-215. doi: 10.1007/978-981-32-9421-9_8. Adv Exp Med Biol. 2019. PMID: 31777020 Review.
Cited by
-
Bioactive Compounds from Medicinal Mushrooms.Adv Biochem Eng Biotechnol. 2023;184:219-268. doi: 10.1007/10_2022_202. Adv Biochem Eng Biotechnol. 2023. PMID: 36244999
-
The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk.Pharm Biol. 2021 Dec;59(1):1161-1171. doi: 10.1080/13880209.2021.1969413. Pharm Biol. 2021. PMID: 34465259 Free PMC article. Review.
-
Purification of ginseng rare sapogenins 25-OH-PPT and its hypoglycemic, antiinflammatory and lipid-lowering mechanisms.J Ginseng Res. 2021 Jan;45(1):86-97. doi: 10.1016/j.jgr.2019.11.002. Epub 2019 Nov 9. J Ginseng Res. 2021. PMID: 33437160 Free PMC article.
-
Modulation of energy metabolism and mitochondrial biogenesis by a novel proteoglycan from Ganoderma lucidum.RSC Adv. 2019 Jan 18;9(5):2591-2598. doi: 10.1039/c8ra09482a. eCollection 2019 Jan 18. RSC Adv. 2019. PMID: 35520529 Free PMC article.
-
Ganoderma lucidum Polysaccharide Peptide Alleviates Cyclophosphamide-Induced Male Reproductive Injury by Reducing Oxidative Stress and Apoptosis.Biomedicines. 2024 Jul 23;12(8):1632. doi: 10.3390/biomedicines12081632. Biomedicines. 2024. PMID: 39200097 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
